Amneal Pharmaceuticals, Inc.
AMRX
Price:
$11.94
Market Cap:
$3.75B
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, p...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-05-07
Stock Exchange
NASDAQ
Ticker
AMRX
PE Ratio
[1.19K]
ROE
[5.06%]
Current Ratio
[2.13]
Dividend Yield
[0%]
Enterprise Value
[6.24B]
Dividend History
The PE Ratio as of December 2025 (TTM) for Amneal Pharmaceuticals, Inc. (AMRX) is 1.19K
According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 1.19K. This represents a change of 1.11% compared to the average of 98.47 of the last 4 quarters.
Amneal Pharmaceuticals, Inc. (AMRX) Historical PE Ratio (quarterly & annually)
How has AMRX PE Ratio performed in the past?
The mean historical PE Ratio of Amneal Pharmaceuticals, Inc. over the last ten years is 9.87. The current 1.19K PE Ratio has changed 1.21% with respect to the historical average. Over the past ten years (40 quarters), AMRX's PE Ratio was at its highest in in the September 2025 quarter at 331.87. The PE Ratio was at its lowest in in the September 2024 quarter at -4128.63.
Average
9.87
Median
3.22
Minimum
-20.94
Maximum
67.14
Amneal Pharmaceuticals, Inc. (AMRX) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 796.23%
Maximum Annual PE Ratio = 67.14
Minimum Annual Increase = -810.25%
Minimum Annual PE Ratio = -20.94
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -20.94 | 65.56% |
| 2023 | -12.65 | 447.24% |
| 2022 | -2.31 | -103.44% |
| 2021 | 67.14 | 796.23% |
| 2020 | 7.49 | -810.25% |
| 2019 | -1.05 | -89.60% |
| 2018 | -10.14 | -188.93% |
| 2017 | 11.41 | -5.54% |
| 2016 | 12.08 | -74.68% |
| 2015 | 47.69 | 40.93% |
Amneal Pharmaceuticals, Inc. (AMRX) Average PE Ratio
How has AMRX PE Ratio performed in the past?
The current PE Ratio of Amneal Pharmaceuticals, Inc. (AMRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.96
5-year avg
7.75
10-year avg
9.87
Amneal Pharmaceuticals, Inc. (AMRX) PE Ratio vs. Peers
How is AMRX’s PE Ratio compared to its peers?
Amneal Pharmaceuticals, Inc.’s PE Ratio is greater than Lantheus Holdings, Inc. (24.81), greater than Supernus Pharmaceuticals, Inc. (-133.42), greater than Indivior PLC (26.05), greater than Telix Pharmaceuticals Limited (143.69), greater than Perrigo Company plc (-36.07), greater than Soleno Therapeutics, Inc. (-35.81), greater than Mirum Pharmaceuticals, Inc. (-87.44), greater than Envista Holdings Corp (222.61), greater than Bausch Health Companies Inc. (7.56), greater than Dyne Therapeutics, Inc. (-5.70),
| Company | PE Ratio | Market cap |
|---|---|---|
| 24.81 | $4.23B | |
| -133.42 | $2.52B | |
| 26.05 | $4.32B | |
| 143.69 | $3.31B | |
| -36.07 | $1.86B | |
| -35.81 | $2.83B | |
| -87.44 | $3.53B | |
| 222.61 | $3.31B | |
| 7.56 | $2.73B | |
| -5.70 | $2.95B |
Build a custom stock screener for Amneal Pharmaceuticals, Inc. (AMRX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Amneal Pharmaceuticals, Inc. (AMRX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Amneal Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the highest PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 3-year average PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 5-year average PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
How does the current PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX) compare to its historical average?